Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer.

Rangiah K, Tippornwong M, Sangar V, Austin D, Tétreault MP, Rustgi AK, Blair IA, Yu KH.

J Proteome Res. 2009 Nov;8(11):5153-64. doi: 10.1021/pr900518v.

2.

Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery.

Yu KH, Barry CG, Austin D, Busch CM, Sangar V, Rustgi AK, Blair IA.

J Proteome Res. 2009 Mar;8(3):1565-76. doi: 10.1021/pr800904z.

3.

Evaluation of strong cation exchange versus isoelectric focusing of peptides for multidimensional liquid chromatography-tandem mass spectrometry.

Slebos RJ, Brock JW, Winters NF, Stuart SR, Martinez MA, Li M, Chambers MC, Zimmerman LJ, Ham AJ, Tabb DL, Liebler DC.

J Proteome Res. 2008 Dec;7(12):5286-94. doi: 10.1021/pr8004666.

4.

Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry.

Shah SJ, Yu KH, Sangar V, Parry SI, Blair IA.

J Proteome Res. 2009 May;8(5):2407-17. doi: 10.1021/pr8010342. Erratum in: J Proteome Res. 2009 Jul;8(7):3786.

5.

Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment.

Zeng X, Yang P, Chen B, Jin X, Liu Y, Zhao X, Liang S.

J Proteomics. 2013 Aug 26;89:51-70. doi: 10.1016/j.jprot.2013.05.032. Epub 2013 Jun 5.

6.

Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.

Mbeunkui F, Metge BJ, Shevde LA, Pannell LK.

J Proteome Res. 2007 Aug;6(8):2993-3002. Epub 2007 Jul 4.

7.

Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.

Wehr AY, Hwang WT, Blair IA, Yu KH.

J Proteome Res. 2012 Mar 2;11(3):1749-58. doi: 10.1021/pr201011f. Epub 2012 Feb 15.

8.

Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis.

Sprung RW Jr, Brock JW, Tanksley JP, Li M, Washington MK, Slebos RJ, Liebler DC.

Mol Cell Proteomics. 2009 Aug;8(8):1988-98. doi: 10.1074/mcp.M800518-MCP200. Epub 2009 May 24.

9.

Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.

Makawita S, Smith C, Batruch I, Zheng Y, Rückert F, Grützmann R, Pilarsky C, Gallinger S, Diamandis EP.

Mol Cell Proteomics. 2011 Oct;10(10):M111.008599. doi: 10.1074/mcp.M111.008599. Epub 2011 Jun 7.

10.

Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.

Whelan SA, He J, Lu M, Souda P, Saxton RE, Faull KF, Whitelegge JP, Chang HR.

J Proteome Res. 2012 Oct 5;11(10):5034-45. doi: 10.1021/pr300606e. Epub 2012 Sep 20.

11.

Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.

Sardana G, Jung K, Stephan C, Diamandis EP.

J Proteome Res. 2008 Aug;7(8):3329-38. doi: 10.1021/pr8003216. Epub 2008 Jun 26.

PMID:
18578523
13.

Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.

Chen CY, Chi LM, Chi HC, Tsai MM, Tsai CY, Tseng YH, Lin YH, Chen WJ, Huang YH, Lin KH.

Mol Cell Proteomics. 2012 Apr;11(4):M111.011270. doi: 10.1074/mcp.M111.011270. Epub 2011 Dec 14.

14.

Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.

Sandim V, Pereira Dde A, Kalume DE, Oliveira-Carvalho AL, Ornellas AA, Soares MR, Alves G, Zingali RB.

Urol Oncol. 2016 Jan;34(1):5.e11-25. doi: 10.1016/j.urolonc.2015.07.016. Epub 2015 Sep 26.

PMID:
26420021
16.

Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment.

Greening DW, Kapp EA, Ji H, Speed TP, Simpson RJ.

Biochim Biophys Acta. 2013 Nov;1834(11):2396-407. doi: 10.1016/j.bbapap.2013.05.006. Epub 2013 May 15.

PMID:
23684732
17.

Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.

Planque C, Kulasingam V, Smith CR, Reckamp K, Goodglick L, Diamandis EP.

Mol Cell Proteomics. 2009 Dec;8(12):2746-58. doi: 10.1074/mcp.M900134-MCP200. Epub 2009 Sep 23.

18.

Systematic evaluation of label-free and super-SILAC quantification for proteome expression analysis.

Tebbe A, Klammer M, Sighart S, Schaab C, Daub H.

Rapid Commun Mass Spectrom. 2015 May 15;29(9):795-801. doi: 10.1002/rcm.7160.

PMID:
26377007
19.

Cysteinyl peptide capture for shotgun proteomics: global assessment of chemoselective fractionation.

Lin D, Li J, Slebos RJ, Liebler DC.

J Proteome Res. 2010 Oct 1;9(10):5461-72. doi: 10.1021/pr1007015.

20.

Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.

Chi LM, Lee CW, Chang KP, Hao SP, Lee HM, Liang Y, Hsueh C, Yu CJ, Lee IN, Chang YJ, Lee SY, Yeh YM, Chang YS, Chien KY, Yu JS.

Mol Cell Proteomics. 2009 Jul;8(7):1453-74. doi: 10.1074/mcp.M800460-MCP200. Epub 2009 Mar 18.

Supplemental Content

Support Center